187 related articles for article (PubMed ID: 38613219)
1. The application strategy of liposomes in organ targeting therapy.
Xun Z; Li T; Xue X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1955. PubMed ID: 38613219
[TBL] [Abstract][Full Text] [Related]
2. Challenges in development of targeted liposomal therapeutics.
Sawant RR; Torchilin VP
AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
[TBL] [Abstract][Full Text] [Related]
3. Composition design and medical application of liposomes.
Li M; Du C; Guo N; Teng Y; Meng X; Sun H; Li S; Yu P; Galons H
Eur J Med Chem; 2019 Feb; 164():640-653. PubMed ID: 30640028
[TBL] [Abstract][Full Text] [Related]
4. Liposomes for cardiovascular targeting.
Levchenko TS; Hartner WC; Torchilin VP
Ther Deliv; 2012 Apr; 3(4):501-14. PubMed ID: 22834079
[TBL] [Abstract][Full Text] [Related]
5. Liposomal Delivery Systems: Design Optimization and Current Applications.
Abu Lila AS; Ishida T
Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
[TBL] [Abstract][Full Text] [Related]
6. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
Almeida B; Nag OK; Rogers KE; Delehanty JB
Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
[TBL] [Abstract][Full Text] [Related]
8. Future directions of liposome- and immunoliposome-based cancer therapeutics.
Park JW; Benz CC; Martin FJ
Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
[TBL] [Abstract][Full Text] [Related]
9. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches.
Kansız S; Elçin YM
Adv Colloid Interface Sci; 2023 Jul; 317():102930. PubMed ID: 37290380
[TBL] [Abstract][Full Text] [Related]
10. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
Wang F; Chen L; Zhang R; Chen Z; Zhu L
J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
[TBL] [Abstract][Full Text] [Related]
11. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
[TBL] [Abstract][Full Text] [Related]
12. Compositional inhomogeneity of drug delivery liposomes quantified at the single liposome level.
Andresen TL; Larsen JB
Acta Biomater; 2020 Dec; 118():207-214. PubMed ID: 33065286
[TBL] [Abstract][Full Text] [Related]
13. An update on liposomes in drug delivery: a patent review (2014-2018).
El-Hammadi MM; Arias JL
Expert Opin Ther Pat; 2019 Nov; 29(11):891-907. PubMed ID: 31603360
[No Abstract] [Full Text] [Related]
14. Magnetically-activated lipid nanocarriers in biomedical applications: A review of current status and perspective.
Sun X; Tan A; Boyd BJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1863. PubMed ID: 36428234
[TBL] [Abstract][Full Text] [Related]
15. Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization.
Makwana V; Karanjia J; Haselhorst T; Anoopkumar-Dukie S; Rudrawar S
Int J Pharm; 2021 Jan; 593():120117. PubMed ID: 33259901
[TBL] [Abstract][Full Text] [Related]
16. Multivesicular Liposome: A Lipid-based Drug Delivery System for Efficient Drug Delivery.
Gorain B; Al-Dhubiab BE; Nair A; Kesharwani P; Pandey M; Choudhury H
Curr Pharm Des; 2021; 27(43):4404-4415. PubMed ID: 34459377
[TBL] [Abstract][Full Text] [Related]
17. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
[TBL] [Abstract][Full Text] [Related]
18. Design of liposomes as drug delivery system for therapeutic applications.
Guimarães D; Cavaco-Paulo A; Nogueira E
Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
[TBL] [Abstract][Full Text] [Related]
19. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical liposomal delivery-specific considerations of innovation and challenges.
Peng T; Xu W; Li Q; Ding Y; Huang Y
Biomater Sci; 2022 Dec; 11(1):62-75. PubMed ID: 36373563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
